Alpha Pharmaceutical Logo Vector
Alpha Pharmaceutical has a pipeline of promising new therapies in development for a variety of diseases, including cancer, central nervous system (CNS) disorders, and infectious diseases. The company's lead product, ALPHA-1 (liposomal alpha-1 antitrypsin), is an investigational new drug (IND) for the treatment of alpha-1 antitrypsin (AAT) deficiency, a rare genetic disorder that can lead to lung and liver disease.
